Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology ...
particularly the role of the VEGF-C/VEGF-D/VEGFR-3 lymphangiogenic signalling pathway, in lymphatic injury underpinning the development of lymphoedema. Results: We demonstrate that radiotherapy ...
Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...
A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...
A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...
A newly identified part of a brain circuit mixes sensory information, memories, and emotions to tell whether things are familiar or new, and important or just 'background noise.' ...
The brain of humans and other animals is known to contribute to the protection of the body from infections. Past studies have ...
In 2025, Canada will unveil four new permanent residency pathways aimed at tackling labor shortages and creating more opportunities for foreign nationals. These initiatives include the Enhanced ...
The proposed pathway by which BCL6 controls muscle is ... less BCL6 leads to less suppressor of cytokine signaling 2 (SOCS2) because BCL6 regulates SOCS2 expression; this, in turn, slows insulin ...
Astronomers say they've detected a mysterious type of signal known as a fast radio burst coming from an ancient, dead galaxy billions of light years away. Figuratively speaking, it makes for one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback